◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Fredun Pharmaceuticals Limited (FREDUN) Financial History

Name: Fredun Pharmaceuticals Limited (FREDUN) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Fredun Pharmaceuticals Limited (FREDUN) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India with about 736 employees. Its market capitalization is roughly ₹22 billion. In the fiscal year ended 2026-03-31, FREDUN reported ₹6.3B in revenue and ₹326M in net income.

Fredun Pharmaceuticals Limited manufactures and sells pharmaceutical formulations, dietary/herbal supplements, nutraceuticals, animal healthcare products, cosmeceuticals, mobility and rehabilitation products, and other healthcare products in India, Africa, Southeast Asia, Commonwealth of Independent States countries, MENA region, and Latin America.

Interactive charts & full statements →

FREDUN Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹6.3B	₹4.5B	₹3.5B	₹2.7B	—
Gross Profit	₹1.7B	₹1.1B	₹730M	₹569M	—
Operating Income (EBIT)	₹942M	₹566M	₹342M	₹250M	—
Net Income	₹326M	₹197M	₹156M	₹108M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

FREDUN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹2.3B	₹2.1B	₹1.6B	₹1.4B	₹1.2B
Gross Profit	₹516M	₹543M	₹459M	₹362M	₹321M
Operating Income (EBIT)	₹292M	₹257M	₹246M	₹204M	₹156M
Net Income	₹131M	₹108M	₹105M	₹94M	₹68M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

FREDUN Free Cash Flow History

FREDUN Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹6.4B	₹4.9B	₹3.1B	₹2.6B	—
Total Liabilities	₹3.6B	₹3.5B	₹1.9B	₹1.6B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive FREDUN viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

SAKAR · Sakar Healthcare Limited — ₹26 billion
SHUKRAPHAR · Shukra Pharmaceuticals Limited — ₹25 billion
INDOCO · Indoco Remedies Limited — ₹23 billion
WINDLAS · Windlas Biotech Limited — ₹23 billion
6887 · Sunshine Lake Pharma Co., Ltd. — HK$21 billion
2929 · Pharma Foods International Co., Ltd. — JPY 21 billion
VENUSREM · Venus Remedies Limited — ₹21 billion
4538 · Fuso Pharmaceutical Industries,Ltd. — JPY 19 billion

← FRE All “F” companies FREI →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.